151 related articles for article (PubMed ID: 24651674)
1. Contribution of environment and genetics to pancreatic cancer susceptibility.
Hocevar BA; Kamendulis LM; Pu X; Perkins SM; Wang ZY; Johnston EL; DeWitt JM; Li L; Loehrer PJ; Klaunig JE; Chiorean EG
PLoS One; 2014; 9(3):e90052. PubMed ID: 24651674
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk.
McWilliams RR; Bamlet WR; Cunningham JM; Goode EL; de Andrade M; Boardman LA; Petersen GM
Cancer Res; 2008 Jun; 68(12):4928-35. PubMed ID: 18544627
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L.
McWilliams RR; Bamlet WR; de Andrade M; Rider DN; Cunningham JM; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1295-302. PubMed ID: 19318433
[TBL] [Abstract][Full Text] [Related]
4. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms in noncoding regions of Rad51C do not change the risk of unselected breast cancer but they modulate the level of oxidative stress and the DNA damage characteristics: a case-control study.
Gresner P; Gromadzinska J; Jablonska E; Stepnik M; Zambrano Quispe O; Twardowska E; Wasowicz W
PLoS One; 2014; 9(10):e110696. PubMed ID: 25343521
[TBL] [Abstract][Full Text] [Related]
6. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
[TBL] [Abstract][Full Text] [Related]
7. Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan.
Shan YS; Chen LT; Wu JS; Chang YF; Lee CT; Wu CH; Chiang NJ; Huang HE; Yen CJ; Chao YJ; Tsai HJ; Chen CY; Kang JW; Kuo CF; Tsai CR; Weng YL; Yang HC; Liu HC; Chang JS
J Biomed Sci; 2020 May; 27(1):69. PubMed ID: 32456644
[TBL] [Abstract][Full Text] [Related]
8. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer.
Jiao L; Bondy ML; Hassan MM; Wolff RA; Evans DB; Abbruzzese JL; Li D
Cancer Detect Prev; 2006; 30(3):284-91. PubMed ID: 16844323
[TBL] [Abstract][Full Text] [Related]
9. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
12. The role of oxidative DNA damage, DNA repair, GSTM1, SOD2 and OGG1 polymorphisms in individual susceptibility to Barrett's esophagus.
Kadioglu E; Sardas S; Ergun M; Unal S; Karakaya AE
Toxicol Ind Health; 2010 Mar; 26(2):67-79. PubMed ID: 20056743
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
[TBL] [Abstract][Full Text] [Related]
14. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer.
Duell EJ; Bracci PM; Moore JH; Burk RD; Kelsey KT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1470-9. PubMed ID: 18559563
[TBL] [Abstract][Full Text] [Related]
15. DNA damage and repair in gastric cancer--a correlation with the hOGG1 and RAD51 genes polymorphisms.
Poplawski T; Arabski M; Kozirowska D; Blasinska-Morawiec M; Morawiec Z; Morawiec-Bajda A; Klupińska G; Jeziorski A; Chojnacki J; Blasiak J
Mutat Res; 2006 Oct; 601(1-2):83-91. PubMed ID: 16843501
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study.
Krechler T; Jachymova M; Pavlikova M; Vecka M; Zeman M; Krska Z; Svestka T; Zak A
Neoplasma; 2009; 56(1):26-32. PubMed ID: 19152242
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.
Duell EJ; Holly EA; Kelsey KT; Bracci PM
Int J Cancer; 2010 Feb; 126(3):790-5. PubMed ID: 19642097
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolic pathway genes and pancreatic cancer risk.
Arem H; Yu K; Xiong X; Moy K; Freedman ND; Mayne ST; Albanes D; Arslan AA; Austin M; Bamlet WR; Beane-Freeman L; Bracci P; Canzian F; Cotterchio M; Duell EJ; Gallinger S; Giles GG; Goggins M; Goodman PJ; Hartge P; Hassan M; Helzlsouer K; Henderson B; Holly EA; Hoover R; Jacobs EJ; Kamineni A; Klein A; Klein E; Kolonel LN; Li D; Malats N; Männistö S; McCullough ML; Olson SH; Orlow I; Peters U; Petersen GM; Porta M; Severi G; Shu XO; Visvanathan K; White E; Yu H; Zeleniuch-Jacquotte A; Zheng W; Tobias GS; Maeder D; Brotzman M; Risch H; Sampson JN; Stolzenberg-Solomon RZ
PLoS One; 2015; 10(3):e0117574. PubMed ID: 25799011
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Kulig A; Malecka-Panas E
Neoplasma; 2009; 56(1):56-62. PubMed ID: 19152246
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic CYP2A6 variation and the risk of pancreatic cancer.
Kadlubar S; Anderson JP; Sweeney C; Gross MD; Lang NP; Kadlubar FF; Anderson KE
JOP; 2009 May; 10(3):263-70. PubMed ID: 19454817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
